Detalhe da pesquisa
1.
CD4+ T cell activation distinguishes response to anti-PD-L1+anti-CTLA4 therapy from anti-PD-L1 monotherapy.
Immunity
; 57(3): 541-558.e7, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38442708
2.
Exploring long-term responses to immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell carcinoma.
Oral Oncol
; 149: 106664, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38113661
3.
Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection.
Nat Commun
; 14(1): 4359, 2023 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37468466
4.
Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in immune checkpoint inhibitor-related pneumonitis.
J Immunother Cancer
; 10(9)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36171010
5.
A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling.
Cell Res
; 30(9): 745-762, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32561858